Member Info for Porter_

Yep, ready for all go in January, shaking out the last of the weak hands before lift off!

Could Genflow products be on shelves any day?

https://exoxpert.com/

Everything Eric marked on his roadmap he’s delivered to date, so I’m very excited at what 2025 will bring. It’s literally just over 3 weeks away so not too long to wait!

As long as we stay at these levels I’ll continue to tap away, snaffle from weak hands and add some more shares to the portfolio too :)

It would be great if a pet partner deal was disclosed money.

I’m suspecting 2025 will be a transformative year for the company.

My understanding is animal trials for pet line products don’t have as much regulatory red tape and can expressed, in comparison to human pharma.

No doubt if the team get confirmation that the patent office intend to award the patents, that will also help raise the publics interest in Genflow!

Longevity and Anti-senescence Therapy Global Market is set to reach $36.11 billion by 2028 at a CAGR of 6.4%… this expansion in recent years can be credited to various factors including increasing life expectancy, rising awareness of preventive healthcare, major breakthroughs in gene therapy, development in regenerative medicine, and growing global elderly populations.

Great news for Genflow Biosciences! #GENF #GENFF

https://www.einnews.com/amp/pr_news/763601243/longevity-and-anti-senescence-therapy-global-market-is-set-to-reach-36-11-billion-by-2028-at-a-cagr-of-6-4

The trade machine is definitely broken this week Money. We can just about see the variance to work out what’s a buy and what’s a sell. I just pity those that are getting spooked into selling, knowing that Eric promised a bumper 2025, meaning they’re going to miss out on the party 🥳

I couldn’t believe it when I saw it Money.

Kennedy and O’Neill could be our dream team in proactive, instead of reactive healthcare.

Genflow has historically been successful at EU government grants, but this change in government could open up the company to so many more prospects, especially if ageing as noted in the article does get reclassified as a disease.

Remember this time at ground zero, exciting times!!!

Boots getting filled from the weak to the strong. Merry Xmas everyone! 😂

Thanks for sharing Money!

It was definitely around this time frame that Eric was awarded his last patent, so it’s certainly an exciting time to be in Genflow.

I religiously check the patent status’s and am keeping the fingers crossed 🤞🏻

Nice to see a ratio of 3:1 with the buys and up 5% on the day :)

I managed to get the extra shares I wanted Money, so will be more than happy for some updates now. No doubt there are plenty of prospective updates that could land and everyone’s patience will have paid off :)

Agree Nadroj, with all the cash they’ve managed to get together, we should hopefully start to see some evidence of material product, or news on the 2 patents.

I think in addition to the IPO, they’ve managed to get access to over 12m Euro's which is pretty decent =

- 22nd October 2024 - 4m Euro's non dilutive grant / loan (Wallonia Region)

- 30th May 2024 - 800,000 Euro's non dilutive grant (Government of Wallonia in Belgium's Advanced Therapy Medicinal Products)

- 4th April 2024 - £715,000 Capital Plus Partners placing

- 18th January 2024 - 1.34m Euro's non dilutive grant

- 18th January 2024 - 1.55m Euro's non dilutive grant

- 11th October 2022 - 250,000 Euro's non dilutive grant (Applied Research Programme of Enterprise Estonia)

- 16th March 2022 - 3.375m Euro's non dilutive grant (Regional Government of Wallonia)

Happy for correction on any mis-statements :)

Quite exciting to listen to Robert F Kennedy Jr at the helm of influencing US healthcare. He is certainly passionate about longevity, health and wellbeing:

https://podcasts.apple.com/gb/podcast/longevity-optimization-with-kayla-barnes-lentz/id1591130227?i=1000618876889

Could we actually see him enforce what he stated last year, with proactive as opposed to reactive healthcare, and a focus on natural food supplements? 🤝

Can’t believe this was 2 weeks ago already:

Genflow Biosciences (LON:GENF) (OTCQB:GENFF) is glad to announce that it has received official confirmation of €4,026,525 in non-dilutive financial support from the Wallonia region to support its MASH research.

The funds are expected to cover three years of Genflow's development program for GF-1002, with the first installment being received as working capital.

Read the release here: https://loom.ly/awLvA4A

#GENF #GENFF #biotech #SIRT6 #MASH

“The health-care industry has seen $253 billion worth of deals announced this year, according to data compiled by Bloomberg.”

With $5bn deals like that at Advent standard business in Pharma, I’m becoming more confident by the day in my investment in Genflow Biosciences.

https://finance.yahoo.com/news/advent-mulls-5-billion-sale-104206260.html

It does sound very exciting! When Genflow was launched, Eric clearly stated in his roadmap, his goal was to have a pet partner by the end of 2024.

He’s always delivered on every objective to date and I believe he’s never given us one ounce of bad news, so I have no reason not to believe a pet deal will be secured.

Thanks for sharing Money. This is my focus:

“it's very likely that we'll see a big move from big pharma and a major wave of acquisition of the FEW longevity companies”

I thought it worth mentioning one of Eric’s other patents. Note the time frame from filing the application, to the publishing of the intention to award the patent.

It proves Eric and the team are credible scientists and don’t need to prove their worth to anyone.

Based on precedent, Genflow could have their first patent approval any day:

https://register.epo.org/application?number=EP15822892

In Genflow we trust!

Evening NE, back at you!

Owing to our growing aged population, the government are realising it’s better to encourage proactive healthcare as opposed to reactive to help protect the NHS!

Maybe as Eric predicted we will actually see ageing be classed as a disease, with governments and corporations taking longevity more seriously 😁

Parliament certainly see it as a positive contribution and are keen to fund science and technology!

Not too many organisations would have the paperwork already in order to meet the deadline, but given the great work Genflow have done recently gaining funding in Europe, surely they can meet the compliance requirements!

It would be amazing if the team could add a chunky UK grant, from a slice of that £1.8bn into the mix.

Here’s the full debate!

https://m.youtube.com/watch?v=B6Uivr_GIO8